APLIF
Appili Therapeutics Inc

158
Mkt Cap
$3.64M
Volume
11,000.00
52W High
$0.0309
52W Low
$0.0089
PE Ratio
-1.08
APLIF Fundamentals
Price
$0.0148
Prev Close
$0.0186
Open
$0.0175
50D MA
$0.0155
Beta
0.64
Avg. Volume
31,755.95
EPS (Annual)
-$0.0156
P/B
-0.17
Rev/Employee
$10,316.00
Loading...
Loading...
Appili Therapeutics, Inc. operates as a biopharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as ATI-1501, ATI-1503, and ATI-1701. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
7

Frequently Asked Questions

What is Market Cap of Appili Therapeutics Inc?
What is the 52-week high for Appili Therapeutics Inc?
What is the 52-week low for Appili Therapeutics Inc?
What is Appili Therapeutics Inc stock price today?
What was Appili Therapeutics Inc stock price yesterday?
What is the PE ratio of Appili Therapeutics Inc?
What is the Price-to-Book ratio of Appili Therapeutics Inc?
What is the 50-day moving average of Appili Therapeutics Inc?
How many employess does Appili Therapeutics Inc has?

Latest APLIF News

View
No APLIF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.